Prospective diagnostic accuracy study assesses biomarkers for diagnosing SBP in cirrhosis patients, suggesting effectiveness.
Fecal calprotectin and serum PCT are promising, readily measurable biomarkers for the diagnosis of SBP in patients with cirrhosis.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: